Switch to:
More From Other Websites
A Look At Puma Biotechnology Inc (PBYI)’s Breast Cancer Candidate Jul 25 2016
Is This the Turning Point Puma Biotech Investors Have Waited For? Jul 22 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Jul 22 2016
Puma Biotech shares jump on breast cancer study, FDA application Jul 21 2016
Puma Biotechnology Announces Interim 5-Year Disease Free Survival Data from Phase III Trial of PB272... Jul 21 2016
Puma Biotechnology Submits New Drug Application for PB272 (Neratinib) to U.S. FDA for Extended... Jul 21 2016
Puma (PBYI) Stock Up, Phase II Data on Neratinib Published Jul 08 2016
Puma Biotechnology Announces I-SPY 2 Phase II Study of Neratinib Published in The New England... Jul 07 2016
Puma Biotechnology Announces I-SPY 2 Phase II Study of Neratinib Published in The New England... Jul 07 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events Jul 06 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events Jun 28 2016
Puma (PBYI) Submits Neratinib Marketing Application in EU Jun 28 2016
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended... Jun 27 2016
Puma Biotechnology Submits Marketing Authorization Application for PB272 (Neratinib) as Extended... Jun 27 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Jun 15 2016
PUMA BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events Jun 06 2016
Puma (PBYI) Presents Favorable Phase II Data on Neratinib Jun 06 2016
Puma Biotechnology Presents Positive Phase II Data at the 2016 ASCO Annual Meeting Jun 05 2016
Puma Biotechnology Presents Positive Phase II Data at the 2016 ASCO Annual Meeting Jun 05 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK